Neuronal nuclear antigen (NeuN): A useful marker of neuronal immaturity in sudden unexplained perinatal death

https://doi.org/10.1016/j.jns.2013.03.012Get rights and content

Abstract

Introduction

In the developing brain neuronal differentiation is associated with permanent exit from the mitotic cycle. Neuronal nuclear antigen (NeuN) is a nuclear protein widely expressed in the mature postmitotic neurons.

Methods

We applied NeuN immunocytochemistry in 65 cases of perinatal death (16 victims of sudden intrauterine unexplained death syndrome/SIUDS, 19 of sudden infant death syndrome/SIDS and 30 controls) to test the physiological status of the brain neurons. In addition we applied both TUNEL and Caspase 3 immunohistochemical methods in order to highlight a possible relation between decreased NeuN expression and apoptotic outcome. We also attempted to see whether or not NeuN pathological changes can be related to cigarette smoke absorption in pregnancy.

Results

NeuN staining was considerably reduced or lost in SIUDS/SIDS compared to controls. However neurons with decreased NeuN-labeling showed no sign of apoptosis. A significant association was found between NeuN depletion and maternal smoking.

Conclusion

Altered NeuN expression can be a marker of immature and/or suffering neurons. The exclusive presence of this pattern of expression in SIUDS/SIDS victims, leads us to recommend the NeuN immunohistochemistry as a routine method in neuropathological protocols to convalidate a diagnosis of sudden perinatal death.

Introduction

The neuronal nuclear antigen (NeuN) is a specific protein expressed in post-mitotic neurons. The corresponding antibody, developed by Mullen in 1992 [1], primarily stains the neuronal nucleus, but the cytoplasm and dendrites are also immunoreactive, though to a lesser extent. Noteworthy it does not stain the immature nerve cells until they exit from the cell cycle and achieve a stage of development that at least approaches mature function. This is coincident with the migration of the neuroblasts from their birthplace in the embryonic neural tube to their final position, outgrowth of axons and generation of synapses [2], [3], [4], [5].

With the inexplicable exception of several neuronal cell types, such as the Purkinje cells and the dentate nucleus neurons in the cerebellum, the neurons of the inferior olivary nucleus in the medulla oblongata and the glial cells, that generally are not recognized by the NeuN antibody, the vast majority of neurons is strongly NeuN positive already in fetal life [1], [2].

In addition to representing a marker of maturing neurons, the NeuN immunohistochemistry can be applied in neuropathologic studies to highlight their physiological status. Precisely, while intense NeuN expression is shown by healthy neurons, a decreased NeuN positivity in postembryonic life can be indicative of degeneration of differentiated neurons. In particular, immunoreactivity is significantly weakened after a severe injury, such as cerebral hypoxia/ischemia [6], [7], [8]. Infants who have suffered fetal distress or perinatal asphyxia may show less brain NeuN immunostaining than infants who have not experienced such insults [2].

Stressors, such as hypoxia, hypercarbia and asphyxia are known as pathogenetic factors in SIDS [9], [10], [11], [12], resulting in functional and/or morphological developmental alterations of brain neurons. Nevertheless, among the countless existing works in the literature on this field, our previous contributions included, there are no reports taking into consideration the NeuN expression as index of neuronal distress in SIDS.

Insofar, we aimed to evaluate the immunoexpression of NeuN in a group of victims already object of our prior studies but not formerly investigated in this regard. We reconsidered a total of 65 subjects aged from 17 gestational weeks to 10 postnatal months, who had died of known or unknown causes. Our aims were firstly to obtain basic information about the manifestation of NeuN in the study groups and to evaluate a possible wrong expression in sudden perinatal and infant death, in addition to specific morpho-functional alterations of the autonomic nervous system we had already reported [13], [14], [15], [16], [17], [18], [19]. Then, in order to evaluate if the NeuN depletion can be indicative of neuronal degeneration, we applied the TUNEL method as hallmark of apoptosis [20], [21] and Caspase3 immunohistochemistry as a signal of dying cells [22].

Finally, we considered a possible correlation between NeuN pathological changes and hypoxic injuries related to cigarette smoke absorption in pregnancy.

Section snippets

Methods

A total of 65 brains were considered for this study, from 29 fresh ante-partum stillbirths (17–40 gestational weeks—gw, mean age: 37 gw), and 36 infants aged between 1 and 10 months (mean age: 3.5 months).

For each case, a complete clinical history, with particular reference to the maternal lifestyle, and including the death scene examination for infant victims, was collected. None of the mothers had any significant pathology. The mothers were also asked for information about the smoking habit

Results

Table 2 shows the NeuN expression scores observed in victims of perinatal death.

In control cases, from the 27th week of gestation to 10 postnatal months, the major part of the neurons exhibited NeuN immunostaining. In particular, the examination of the griseum pontis, the selected region as standard parameter to compare the results, showed in 24 out of 30 control cases strong NeuN-immunoreactivity in almost all the neuronal cell population (Score ++). The staining was present in both nuclei and

Discussion

The application of the immunohistochemistry using antiNeuN antibody provides the neuropathologists with an easy method to examine the stage of maturation and differentiation of the human CNS. NeuN is in fact a transcriptional factor that is expressed in the nucleus and cytoplasm of neurons in postmitotic stage when start to differentiate into mature cells functionally and morphologically [1], [2]. So, immature neuronal cells are negative for NeuN.

Even if NeuN immunopositivity appears diffuse in

Conflict of interest

All authors declare that they have no conflicts of interest, financial or otherwise to declare.

Acknowledgments

This study was supported by the Italian Health Ministry in accordance with Law 31/2006 “Regulations for Diagnostic Post Mortem Investigation in Victims of Sudden Infant Death Syndrome (SIDS) and Unexpected Fetal Death” and by the Convention between the Provincia autonoma di Trento and the "Lino Rossi" Research Center of the University of Milan, Italy.

References (39)

  • W. Lichtensteiger et al.

    Prenatal adverse effects of nicotine on the developing brain

    Prog Brain Res

    (1988)
  • R.J. Mullen et al.

    NeuN, a neuronal specific nuclear protein in vertebrates

    Development

    (1992)
  • A. Weyer et al.

    Development and cell type-specific expression of the neuronal marker NeuN in the murine cerebellum

    J Neurosci Res

    (2003)
  • H.K. Wolf et al.

    NeuN: a useful neuronal marker for diagnostic histopathology

    J Histochem Cytochem

    (1996)
  • R. Schmidt-Kastner et al.

    Monoclonal antibody to NeuN as specific marker for neurons in immunohistochemical evaluation of global ischemic damage in rat

    J Cereb Blood Flow Metab

    (1995)
  • P.N. Goldwater

    Sudden infant death syndrome: a critical review of approaches to research

    Arch Dis Child

    (2003)
  • H.F. Krous et al.

    Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach

    Pediatrics

    (2004)
  • H.C. Kinney

    Brainstem mechanisms underlying the sudden infant death syndrome: evidence from human pathologic studies

    Dev Psychobiol

    (2009)
  • A.M. Lavezzi et al.

    Preliminary study on the cytoarchitecture of the human parabrachial/Kölliker–Fuse complex with reference to sudden infant death syndrome and sudden intrauterine unexplained death

    Pediatr Dev Pathol

    (2004)
  • Cited by (0)

    View full text